BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7552950)

  • 21. Oral mucosal Langerhans cells express DR and DQ antigens.
    Walsh LJ; Seymour GJ; Savage NW
    J Dent Res; 1986 Mar; 65(3):390-3. PubMed ID: 3457041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The distribution of Langerhans cells and CD1a antigen in healthy and diseased human gingiva.
    Crawford JM; Krisko JM; Morris GA; Chambers DA
    Reg Immunol; 1989; 2(2):91-7. PubMed ID: 2484334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of MHC class II antigens (HLA-DR, -DP, and -DQ) on human gastric epithelium.
    Ishii N; Chiba M; Iizuka M; Watanabe H; Ishioka T; Masamune O
    Gastroenterol Jpn; 1992 Feb; 27(1):23-8. PubMed ID: 1555745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.
    de Boer OJ; van der Loos CM; Hamerlinck F; Bos JD; Das PK
    Arch Dermatol Res; 1994; 286(2):87-96. PubMed ID: 7512323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis.
    Gruschwitz M; Sepp N; Kofler H; Wick G
    Immunobiology; 1991 Jun; 182(3-4):234-55. PubMed ID: 1833311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of HLA-DQ and -DP restriction elements in T-cell responses to soluble antigens: mutational analysis.
    Mellins E; Woelfel M; Pious D
    Hum Immunol; 1987 Mar; 18(3):211-23. PubMed ID: 3032874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia.
    Hughes RG; Norval M; Howie SE
    J Clin Pathol; 1988 Mar; 41(3):253-9. PubMed ID: 2834416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA antigen expression on cultured human arterial endothelial cells.
    Markus BH; Colson YL; Fung JJ; Zeevi A; Duquesnoy RJ
    Tissue Antigens; 1988 Nov; 32(5):241-53. PubMed ID: 3146825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On quantification of CD1a, HLA-DR, and HLA class I expression on viable human Langerhans cells and keratinocytes.
    Sprogøe-Jakobsen U; Lillevang ST; Kristensen T
    Cytometry; 1997 Aug; 30(4):206-7. PubMed ID: 9298841
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential abilities of human peripheral blood monocytes quantitatively or qualitatively differing in HLA-DR and HLA-DS expression to support B cell activation in liquid and semisolid cultures.
    Whisler RL; Newhouse YG; Lachman LB
    J Immunol; 1985 Jul; 135(1):172-9. PubMed ID: 3873488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down's syndrome and celiac disease: the prevalence of high IgA-antigliadin antibodies and HLA-DR and DQ antigens in trisomy 21.
    Castro M; Crinò A; Papadatou B; Purpura M; Giannotti A; Ferretti F; Colistro F; Mottola L; Digilio MC; Lucidi V
    J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):265-8. PubMed ID: 8492253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gingival keratinocytes express HLA-DR antigens in chronic gingivitis.
    Walsh LJ; Seymour GJ; Powell RN
    J Oral Pathol; 1985 Apr; 14(4):315-21. PubMed ID: 2582104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of CD1a, HLA-DR, and HLA class I expression on viable human Langerhans cells and keratinocytes.
    Meunier L; Vian L; Lagoueyte C; Lavabre-Bertrand T; Duperray C; Meynadier J; Cano JP
    Cytometry; 1996 Dec; 26(4):260-4. PubMed ID: 8979024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA typing of HLA class II genes (HLA-DR, -DQ and -DP) in Japanese patients with histiocytic necrotizing lymphadenitis (Kikuchi's disease).
    Tanaka T; Ohmori M; Yasunaga S; Ohshima K; Kikuchi M; Sasazuki T
    Tissue Antigens; 1999 Sep; 54(3):246-53. PubMed ID: 10519361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of HLA-DR, DP, and DQ expression in activated T cells.
    Gansbacher B; Zier KS
    Cell Immunol; 1988 Nov; 117(1):22-34. PubMed ID: 3263216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal urothelial HLA-DR expression in interstitial cystitis.
    Christmas TJ; Bottazzo GF
    Clin Exp Immunol; 1992 Mar; 87(3):450-4. PubMed ID: 1544229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MHC class II antigen expression in normal human epidermis.
    Carr MM; McVittie E; Guy K; Gawkrodger DJ; Hunter JA
    Immunology; 1986 Oct; 59(2):223-7. PubMed ID: 2429921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.